← Insider buys
RGLS

Regulus Therapeutics Inc.

President and CEO Joseph P Hagan sold $48K of Regulus Therapeutics Inc.

Sold$47,966
$1.22Price
39,352Shares
−13%Stake

What RGLS did after the filing

Prices for RGLS after this filing aren't in yet.

Traded Thu, May 16. Filed Thu, May 16, 1:25 PM ET, during the session. Not investment advice.